Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRISABOROLE vs CRIZANLIZUMAB-TMCA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CRISABOROLE vs CRIZANLIZUMAB-TMCA: Safety Overview

Metric CRISABOROLE CRIZANLIZUMAB-TMCA
Total FAERS Reports 7,784 1,130
Deaths Reported 22 37
Death Rate 0.3% 3.3%
Hospitalizations 53 435
Average Patient Age 39.7 yrs 29.9 yrs
% Female Patients 65.9% 63.6%
FDA Approval Date Dec 14, 2016 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route TOPICAL N/A
Marketing Status Prescription Prescription